177 related articles for article (PubMed ID: 27791011)
1. Data-driven identification of prognostic tumor subpopulations using spatially mapped t-SNE of mass spectrometry imaging data.
Abdelmoula WM; Balluff B; Englert S; Dijkstra J; Reinders MJ; Walch A; McDonnell LA; Lelieveldt BP
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12244-12249. PubMed ID: 27791011
[TBL] [Abstract][Full Text] [Related]
2. Intratumor Heterogeneity in Breast Cancer.
Beca F; Polyak K
Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers.
Mandel J; Wang H; Normolle DP; Chen W; Yan Q; Lucas PC; Benos PV; Prochownik EV
BMC Cancer; 2019 Jul; 19(1):686. PubMed ID: 31299925
[TBL] [Abstract][Full Text] [Related]
4. Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer.
Wang L; Wrobel JA; Xie L; Li D; Zurlo G; Shen H; Yang P; Wang Z; Peng Y; Gunawardena HP; Zhang Q; Chen X
Cell Chem Biol; 2018 May; 25(5):619-633.e5. PubMed ID: 29503206
[TBL] [Abstract][Full Text] [Related]
5. Analyzing the similarity of samples and genes by MG-PCC algorithm, t-SNE-SS and t-SNE-SG maps.
Jia X; Han Q; Lu Z
BMC Bioinformatics; 2018 Dec; 19(1):512. PubMed ID: 30558536
[TBL] [Abstract][Full Text] [Related]
6. Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer.
Gallenne T; Ross KN; Visser NL; Salony ; Desmet CJ; Wittner BS; Wessels LFA; Ramaswamy S; Peeper DS
Oncotarget; 2017 Mar; 8(13):20572-20587. PubMed ID: 28411283
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry Imaging for the Investigation of Intratumor Heterogeneity.
Balluff B; Hanselmann M; Heeren RM
Adv Cancer Res; 2017; 134():201-230. PubMed ID: 28110651
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
9. De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry.
Balluff B; Frese CK; Maier SK; Schöne C; Kuster B; Schmitt M; Aubele M; Höfler H; Deelder AM; Heck A; Hogendoorn PC; Morreau J; Maarten Altelaar AF; Walch A; McDonnell LA
J Pathol; 2015 Jan; 235(1):3-13. PubMed ID: 25201776
[TBL] [Abstract][Full Text] [Related]
10. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Bcl-2 and p53 expression in gastric cancer.
Lee HK; Lee HS; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Int J Colorectal Dis; 2003 Nov; 18(6):518-25. PubMed ID: 12811476
[TBL] [Abstract][Full Text] [Related]
12. Research Techniques Made Simple: Mass Cytometry Analysis Tools for Decrypting the Complexity of Biological Systems.
Matos TR; Liu H; Ritz J
J Invest Dermatol; 2017 May; 137(5):e43-e51. PubMed ID: 28411844
[TBL] [Abstract][Full Text] [Related]
13. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
[TBL] [Abstract][Full Text] [Related]
14. Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis.
Ye P; Zhang M; Fan S; Zhang T; Fu H; Su X; Gavine PR; Liu Q; Yin X
PLoS One; 2015; 10(11):e0143207. PubMed ID: 26587992
[TBL] [Abstract][Full Text] [Related]
15. In silico analysis of stomach lineage specific gene set expression pattern in gastric cancer.
Pandi NS; Suganya S; Rajendran S
Biochem Biophys Res Commun; 2013 Oct; 439(4):539-46. PubMed ID: 24025679
[TBL] [Abstract][Full Text] [Related]
16. VEZT as a novel independent prognostic factor in gastric cancer.
Li YS; Chen YZ; Guo XB; Liu X; Li LP
Cancer Biomark; 2015; 15(4):375-80. PubMed ID: 25792470
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects.
Cherdyntseva NV; Litviakov NV; Denisov EV; Gervas PA; Cherdyntsev ES
Exp Oncol; 2017 Mar; 39(1):2-11. PubMed ID: 28361862
[TBL] [Abstract][Full Text] [Related]
18. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.
Su Z; Zhao J; Rong Z; Geng W; Wang Z
Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
20. MiR-4728-3p could act as a marker of HER2 status.
Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
